Stock Analysis

At €62.44, Is It Time To Put Brenntag SE (ETR:BNR) On Your Watch List?

XTRA:BNR
Source: Shutterstock

While Brenntag SE (ETR:BNR) might not be the most widely known stock at the moment, it received a lot of attention from a substantial price movement on the XTRA over the last few months, increasing to €71.02 at one point, and dropping to the lows of €59.18. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Brenntag's current trading price of €62.44 reflective of the actual value of the mid-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Brenntag’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

See our latest analysis for Brenntag

What Is Brenntag Worth?

Good news, investors! Brenntag is still a bargain right now. My valuation model shows that the intrinsic value for the stock is €90.70, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. What’s more interesting is that, Brenntag’s share price is quite volatile, which gives us more chances to buy since the share price could sink lower (or rise higher) in the future. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

What kind of growth will Brenntag generate?

earnings-and-revenue-growth
XTRA:BNR Earnings and Revenue Growth September 26th 2022

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Though in the case of Brenntag, it is expected to deliver a relatively unexciting earnings growth of 7.8%, which doesn’t help build up its investment thesis. Growth doesn’t appear to be a main reason for a buy decision for the company, at least in the near term.

What This Means For You

Are you a shareholder? Even though growth is relatively muted, since BNR is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. However, there are also other factors such as financial health to consider, which could explain the current undervaluation.

Are you a potential investor? If you’ve been keeping an eye on BNR for a while, now might be the time to enter the stock. Its future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy BNR. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed buy.

In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. Be aware that Brenntag is showing 3 warning signs in our investment analysis and 2 of those make us uncomfortable...

If you are no longer interested in Brenntag, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

If you're looking to trade Brenntag, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

Sponsored Content

Valuation is complex, but we're here to simplify it.

Discover if Brenntag might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About XTRA:BNR

Brenntag

Brenntag SE purchases and supplies various industrial and specialty chemicals, and ingredients in Germany, the United States, France, Canada, the United Kingdom, Singapore, China, Italy, Spain, Poland, and internationally.

Established dividend payer and good value.